Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS Augmented by D-Cycloserine for Depression
NCT00869765Phase 2Completed
- Sponsor
- University of New South Wales
- Start
- Apr 2009
- Primary completion
- Sep 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of d-cycloserine in major depressive disorder (MDD), sponsored by University of New South Wales. Primary endpoint: Inventory of Depressive Symptomatology at 6 months. Started Apr 2009; status: completed.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00869765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869765.